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For common cancers, survival is poorer for deprived and outlying, rural patients. This study investigated whether there were
differences in treatment of colorectal and lung cancer in these groups. Case notes of 1314 patients in north and northeast
Scotland who were diagnosed with lung or colorectal cancer in 1995 or 1996 were reviewed. On univariate analysis, the
proportions of patients receiving surgery, chemotherapy and radiotherapy appeared similar in all socio-economic and rural
categories. Adjusting for disease stage, age and other factors, there was less chemotherapy among deprived patients with lung
cancer (odds ratio 0.39; 95% conﬁdence intervals 0.16 to 0.96) and less radiotherapy among outlying patients with colorectal
cancer (0.39; 0.19 to 0.82). The time between ﬁrst referral and treatment also appeared similar in all socio-economic and rural
groups. Adjusting for disease stage and other variables, times to lung cancer treatment remained similar, but colorectal cancer
treatment was quicker for outlying patients (adjusted hazard ratio 1.30; 95% conﬁdence intervals 1.03 to 1.64). These ﬁndings
suggest that socio-economic status and rurality may have a minor impact on modalities of treatment for colorectal and lung
cancer, but do not lead to delays between referral and treatment.
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Lung and colorectal cancers are two of the most commonly diag-
nosed cancers and the most common causes of cancer related death
in Scotland (ISD, 2001). Several studies in different countries have
found that survival from these cancers varies with socio-economic
and geographical factors (Kogevinas and Porta, 1997; Campbell et
al, 2000). In a recent analysis of Scottish cancer registry data, survi-
val from lung and colorectal cancer was poorer for patients
resident in the most deprived areas compared to those in the least
deprived areas (McLaren and Bain, 1998). Another analysis of this
data found that, compared with those living in towns and cities
with cancer centres, adjusted survival for patients living in rural
areas was 9% poorer for lung and 11% poorer for colorectal cancer
(Campbell et al, 2000).
Stage at diagnosis and treatment are the principal determinants
of cancer survival (Auvinen and Karjalainen, 1997). We and others
have shown that patients in rural areas have more advanced disease
at diagnosis (Liff et al, 1991; Launoy et al, 1992; Campbell et al,
2001) but the relationship between stage and socio-economic status
remains unclear with conﬂicting results in different studies (Auvi-
nen and Karjalainen, 1997; Ionescu et al, 1998). With regard to
treatment, there are some indications that management is poorer
for rural patients with lung cancer in North America (Greenberg
et al, 1988) and colorectal cancer in France (Launoy et al, 1992).
Similarly, deprived patients with colorectal cancer were found to
have poorer treatment in Finland (Auvinen and Karjalainen,
1997). A study of computerised hospital discharge data in Scotland
has suggested that patients with colorectal cancer from deprived
areas are less likely to be treated with chemotherapy (McLeod,
1999). Overall, however, research ﬁndings have been conﬂicting
and little has been reported in the United Kingdom (Auvinen
and Karjalainen, 1997). In this study, we investigated whether there
were variations in treatment of colorectal and lung cancer with
socio-economic deprivation and urban/rural residence.
PATIENTS AND METHODS
This was a historical cohort study. Details of sampling and data
collection have been described previously (Campbell et al, 2001).
Brieﬂy, all patients diagnosed with colorectal or lung cancer in
north or northeast Scotland in 1995 and 1996 were identiﬁed by
the Scottish cancer registry and a random sample of 1398 selected,
weighted to ensure equal numbers of lung and colorectal cancers
and urban and rural participants. Sets of case notes could be
obtained from teaching and general hospitals in Grampian and
Highland for 1323 (95%) of the cohort. Clinical data were
abstracted in a standardised manner. There were no important
differences in patient characteristics between cases whose notes
were reviewed and those whose notes were not traced (Campbell
et al, 2001). Nine patients died the same day that they were diag-
nosed so were excluded from follow up, leaving 1314 cases for
analysis.
The main outcomes of the study were surgery, radiotherapy and
chemotherapy within 1 year of diagnosis and the length of time
between ﬁrst referral (date of referral letter, or ﬁrst contact with
hospital if there was no referral) and ﬁrst treatment with surgery,
radiotherapy or chemotherapy.
The main independent variables were material deprivation (as a
proxy for socio-economic status) and urban-rural status. Indicators
of deprivation and urban-rural status were assigned to cases
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www.bjcancer.comare the smallest unit of population on which census data are avail-
able in Scotland (median population 130), are more sensitive than
larger areas when measuring socio-economic deprivation and
geographical location in rural areas (Reading et al, 1993; Campbell
et al, 2000). Carstairs deprivation scores were calculated from 1991
census data at the output area level and grouped into population
quintiles (Carstairs and Morris, 1990). Distance to the nearest
cancer centre (in Aberdeen or Inverness) was used as the basis of
the indicator of urban-rural status because it has been found to
be associated with poorer survival in previous research in Scotland
(Campbell et al, 2000). Patients were assigned to one of four prede-
ﬁned categories: 0 to 5 km, 6 to 37 km, 38 to 57 km and 558 km
(Campbell et al, 2001). Other variables considered in the analysis
were sex, age, settlement size, health board of residence, previous
history of cancer, and presentation (emergency hospital admission
or not). Cancer site (colon or rectum) and Dukes stage were
considered in the analysis of colorectal cancer, and tumour histol-
ogy (non-small cell or small cell) and ISS stage in the analysis of
lung cancer.
Data were managed using Microsoft Access and analysed using
SPSS for Windows release 9. Data on the two cancers were
analysed separately. Proportions of cases receiving surgery, radio-
therapy and chemotherapy were compared using the chi-square
test and modelled using logistic regression. Differences in time
between referral and ﬁrst treatment were compared using
Kaplan–Meier curves and the log rank test and modelled using
Cox regression.
RESULTS
In all, 661 cases with lung cancer and 653 with colorectal cancer
were included in the analysis. Selected characteristics are shown














1–least deprived 76 (11) 113 (17)
2 111 (17) 121 (19)
3 132 (20) 154 (24)
4 165 (25) 160 (25)
5–most deprived 177 (27) 105 (16)
Distance to centre
45km 223 (34) 195 (30)
6–37 km 101 (15) 127 (19)
38–57 km 150 (23) 161 (25)
558 km 187 (28) 170 (26)
Sex
Male 412 (62) 337 (52)
Female 249 (38) 316 (48)
Age band
459 104 (16) 121 (19)
50–69 212 (32) 159 (24)
70–79 248 (38) 216 (33)
580 97 (15) 157 (24)
Settlement size
4100 000 194 (29) 165 (25)
10 000–100 000 133 (20) 119 (18)
1000–10 000 205 (31) 221 (34)
500–1000 32 (5) 30 (5)
5500 97 (15) 118 (18)
Health board of residence
Grampian 473 (72) 476 (73)
Highland 188 (28) 177 (27)
First primary tumour 596 (90) 596 (91)
Place of ﬁrst referral
General practice 534 (81) 557 (85)
Hospital 59 (10) 35 (6)
Screening 0 4 (51)
Emergency (no referral) 28 (5) 19 (3)
Not known 40 (6) 38 (6)
Emergency hospital admission 228 (34) 220 (34)
Lung histology
Small cell 91 (14)
Non small cell 417 (63)
Not known 153 (23)














Not known 41 (6)
Table 2 Numbers (percentages) of patients with lung and colorectal
cancer who were treated with surgery, radiotherapy and chemotherapy




1 – least deprived 10/76 (13) 39/76 (51) 17/76 (22)
2 13/109 (12) 75/109 (69) 18/109 (17)
3 17/132 (13) 90/132 (68) 29/132 (22)
4 25/161 (16) 94/161 (58) 24/161 (15)
5 – most deprived 20/175 (11) 114/175 (65) 36/175 (21)
P value (global)
a 0.843 0.052 0.435
P value (trend)
b 0.963 0.497 0.797
Distance to centre
45 km 30/222 (14) 131/222 (59) 39/222 (18)
6–37 km 13/101 (13) 68/101 (67) 17/101 (17)
38–57 km 20/148 (14) 100/148 (68) 40/148 (27)
558 km 22/182 (12) 113/182 (62) 28/182 (15)
P value (global)
a 0.974 0.293 0.039
P value (trend)
b 0.721 0.424 0.874
Colorectal cancer
Deprivation quintile
1 – least deprived 104/111 (94) 18/112 (16) 31/111 (28)
2 105/120 (88) 7/120 (6) 26/120 (22)
3 140/150 (93) 17/150 (11) 32/150 (21)
4 141/159 (89) 23/158 (15) 36/159 (23)
5 – most deprived 93/102 (91) 17/103 (17) 20/102 (20)
P value (global)
a 0.319 0.081 0.641
P value (trend)
b 0.602 0.309 0.234
Distance to centre
45 km 176/194 (91) 27/194 (14) 39/194 (20)
6 to 37 km 118/127 (93) 19/126 (15) 31/126 (25)
38 to 57 km 143/156 (92) 21/157 (13) 33/156 (21)
558 km 146/165 (88) 15/166 (9) 42/166 (25)
P value (global)
a 0.597 0.397 0.602
P value (trend)
b 0.472 0.169 0.350
aChi square test.
bChi square test for linear trend.
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2 0.76 (0.28–2.09) 2.08 (1.11–3.91) 0.58 (0.21–1.57)
3 0.70 (0.27–1.84) 2.27 (1.24–4.16) 0.72 (0.29–1.78)
4 0.88 (0.35–2.22) 1.47 (0.83–2.60) 0.41 (0.16–1.05)
5 0.59 (0.23–1.53) 1.86 (1.05–3.28) 0.39 (0.16–0.96)
P value (global) 0.791 0.056 0.189
P value (trend) 0.423 0.378 0.028
Distance to centre
45k m 1 1 1
6–37 km 1.66 (0.73–3.78) 1.18 (0.70–1.98) 1.38 (0.61–3.14)
38–57 km 1.24 (0.61–2.51) 1.52 (0.97–2.38) 1.93 (0.98–3.83)
558 km 1.61 (0.80–3.23) 0.99 (0.65–1.53) 1.43 (0.71–2.85)
P value (global) 0.502 0.257 0.299
P value (trend) 0.246 0.657 0.166
Other variables adjusted for:
Health Board
A1 1 1
B 0.38 (0.19–0.73) 1.71 (1.17–2.50) 0.09 (0.04–0.20)
Emergency admission
No 11
Yes 0.68 (0.48–0.96) 0.40 (0.22–0.72)
Age (per year) 0.91 (0.89–0.94) 0.89 (0.86–0.91)
Tumour
ISS stage I 1 1 1
ISS stage II 0.53 (0.17–1.68) 3.50 (1.21–10.1) 2.92 (0.21–41.1)
ISS stage III 0.39 (0.21–0.71) 2.25 (1.35–3.75) 9.31 (1.98–43.8)
ISS stage IV 0.01 (50.01–0.05) 1.66 (0.99–2.78) 18.6 (3.91–88.7)
Not known 0.13 (0.04–0.41) 0.82 (0.44–1.52) 2.67 (0.32–22.0)





2 0.48 (0.15–1.58) 0.27 (0.10–0.72) 0.86 (0.41–1.81)
3 0.70 (0.20–2.37) 0.61 (0.28–1.32) 0.64 (0.32–1.30)
4 0.51 (0.16–1.58) 0.84 (0.40–1.76) 0.65 (0.33–1.27)
5 0.52 (0.14–1.87) 0.85 (0.38–1.91) 0.49 (0.22–1.10)
P value (global) 0.718 0.050 0.425
P value (trend) 0.394 0.504 0.059
Distance to centre
45k m 1 1 1
6–37 km 1.85 (0.66–5.18) 0.74 (0.36–1.49) 1.27 (0.66–2.45)
38–57 km 1.55 (0.59–4.07) 0.69 (0.35–1.36) 0.91 (0.48–1.73)
558 km 1.69 (0.68–4.18) 0.39 (0.19–0.82) 1.37 (0.74–2.53)
P value (global) 0.599 0.081 0.578
P value (trend) 0.316 0.014 0.517







Age (per year) 0.96 (0.93–0.99) 0.97 (0.95–0.99) 0.91 (0.89–0.93)
Tumour – Dukes stage
A1 1 1
B 9.17 (0.81–103) 4.79 (1.07–21.6) 1.78 (0.61–5.20)
C 3.17 (0.44–23.1) 9.70 (2.17–43.4) 12.4 (4.27–35.7)
D 0.09 (0.02–0.41) 10.8 (2.34–49.3) 12.3 (4.07–37.4)
Not known 0.02 (50.01–0.11) 14.1 (2.62–76.1) 4.35 (0.81–23.3)
Colon 1
Rectum 6.49 (3.86–10.9)
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hospital admissions.
Of 653 patients with lung cancer, 85 (13%) had surgery, 412
(63%) radiotherapy and 124 (19%) chemotherapy in the ﬁrst year
after diagnosis (details of treatment were incomplete for eight
patients). For colorectal cancer, 583 out of 642 (91%) patients
had surgery, 145 out of 642 (23%) chemotherapy and 82 out of
643 (13%) radiotherapy (data on surgery and chemotherapy were
incomplete for 11 patients and on radiotherapy for 10 patients).
On univariate analysis, there were few differences in proportions
of patients receiving surgery, chemotherapy and radiotherapy by
either deprivation or rurality (Table 2). Of the potential confound-
ing variables, disease stage was strongly associated with the
likelihood of all three forms of treatment for both cancers. Age,
health board of residence, mode of presentation (emergency admis-
sion or otherwise), and cancer site (colon or rectum) were
associated with some treatments. Table 3 shows the adjusted odds
ratios for treatment with surgery, radiotherapy and chemotherapy
taking account of these variables. The adjusted ﬁgures suggest that
chemotherapy for both cancers was less likely with increasing
deprivation and these trends are shown in Figure 1. The trend
was borderline insigniﬁcant for colorectal cancer (P=0.059), but
signiﬁcant for lung cancer (P=0.028) where the odds ratio for
chemotherapy in the most deprived group compared to the most
afﬂuent was 0.39 (95% conﬁdence interval 0.16 to 0.96). With
regard to rurality, the likelihood of radiotherapy for colorectal
cancer decreased with increasing distance from the cancer centre
(P (trend)=0.014). The odds ratio for outlying patients with color-
ectal cancer compared to those resident closest to the centre was
0.39 (95% CI 0.19 to 0.82).
Overall, the median time between ﬁrst referral from any source
and ﬁrst treatment with surgery, radiotherapy or chemotherapy
was 34 days for lung cancer and 37 for colorectal cancer. For lung
cancer, there were no differences with deprivation or rurality in
either univariate or multivariate (taking account of stage, age,
and health board) analyses (Table 4 and Figure 2). For colorectal
cancer, there were again no differences on univariate testing, but
adjusting for other signiﬁcant variables (stage and emergency
admission to hospital), outlying patients were treated more quickly
(Table 4 and Figure 2). The hazard ratio for treatment in patients
living more than 58 km from a cancer centre compared to those
within 5 km was 1.30; 95% conﬁdence interval 1.03 to 1.64.
DISCUSSION
We found that in the north and northeast of Scotland, there was
limited evidence that deprivation and rurality were associated with
differences in treatment. There may be some impact on treatment
modalities, but no worsening of treatment delay.
This study has a number of strengths and limitations. The Scot-
tish Cancer Registry has high levels of case ascertainment over a
long period, being reported as at least 96% complete (Brewster
et al, 1997). In this study, the rate of case note retrieval (95%)
was high and we have previously shown that there were no impor-
tant differences between cases whose notes were retrieved and those
whose notes were not (Campbell et al, 2001). The setting for the
study had two cancer centres located in the two main cities,
reasonably close to about half their populations, but with the
remainder spread over a large rural area. This made the compari-
son of rural and urban areas relatively straightforward. On the
other hand, comparison of deprivation categories was more difﬁ-
cult. North and Northeast Scotland do not have the same high
levels of deprivation seen in some other areas (for example, the
central industrial belt of Scotland)–there are, however, signiﬁcant
pockets of deprivation and overall the area is less afﬂuent than, for
example, England and Wales (Carstairs and Morris, 1990). A
second problem is that levels of deprivation are more difﬁcult to
assess in rural areas where afﬂuence and poverty can coexist in
close proximity. In an attempt to improve sensitivity, we calculated










    Surgery
    Radiotherapy
    Chemotherapy
Colorectal cancer
    Surgery
    Radiotherapy



































































Figure 1 Adjust odds ratios (95% conﬁdence intervals) for treatment with surgery, radiotherapy and chemotherapy within 1 year of diagnosis.
aLeast
deprived is ‘1’ and most deprived ‘5'.
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British Journal of Cancer (2002) 87(6), 585–590 ã 2002 Cancer Research UKmethod has been found sensitive enough to detect survival differ-
ences for common cancers in Scotland (Campbell et al, 2000). We
were aware of the importance of disease stage in determining
subsequent treatment and would have liked to have presented stage
speciﬁc analyses, but our numbers were not large enough for these
to provide meaningful ﬁndings. We have, instead, adjusted for
stage at diagnosis in our analyses. Finally, the data we collected
was limited to that which we could readily and reliably obtain from
case notes. We were not, for example, able to collect data on WHO
performance status or multidisciplinary team meetings. This meant
that, although we were able to compare mode and speed of treat-
ment, we were not able to investigate quality of treatment within
each modality. We cannot, therefore, exclude important differences
in the quality of treatment to patients in the groups studied,
although the fact that all patients (rural and urban, afﬂuent and
deprived) in each health board area received specialist oncology
from one hospital, suggests that this is unlikely.
Our ﬁndings add to limited evidence on whether differences in
treatment contribute to poor survival among socio-economically
deprived people with lung and colorectal cancer (Auvinen and
Karjalainen, 1997). In a previous analysis of this dataset, we found
no evidence of more advanced stage at diagnosis among deprived
patients (Campbell et al, 2001). In the current study, although
times between referral and treatment appeared to be long in many
cases (particularly compared to the recommendations published in
the NHS Cancer Plan (Department of Health, 2000)), they were
equally long in all deprivation categories. We found lower likeli-
hood of deprived patients receiving chemotherapy, but this trend
was only detected after adjusting for other variables (and not on
univariate analysis), so needs to be treated with an element of
caution. On the other hand, the trend was present for both cancers
and is in line with a previous study of colorectal cancer treatment
in Scotland, which found the odds ratio of chemotherapy to be
0.73 in deprived compared to afﬂuent areas (McLeod, 1999).
Lower rates of chemotherapy may be a contributory factor in the
poor survival rates of socio-economically deprived people with









Table 4 Time between ﬁrst referral and ﬁrst treatment (surgery, chemo-
therapy or radiotherapy)
Median (Interquartile Adjusted hazard
range)





1 33 (15, 104) 1
2 38 (11, 78) 1.12 (0.79–1.59)
3 39 (17, 81) 1.08 (0.78–1.51)
4 42 (16, 121) 0.94 (0.68–1.30)
5 25 (13, 77) 1.07 (0.78–1.49)
P value (global) 0.152 0.702
P value (trend) 0.480 0.813
Distance to centre
45 km 38 (15, 118) 1
6–37 km 40 (16, 87) 1.06 (0.80–1.40)
38–57 km 25 (13, 55) 1.34 (1.06–1.70)
558 km 39 (14, 87) 1.11 (0.88–1.40)
P value (global) 0.073 0.092
P value (trend) 0.280 0.146
Other variables adjusted for:
Tumour
ISS stage I 61 (23, 147) 1
ISS stage II 52 (25, 118) 1.26 (0.78–2.03)
ISS stage III 33 (14, 72) 1.55 (1.18–2.03)
ISS stage IV 30 (14, 81) 1.43 (1.07–1.90)
Not known 78 (18, 4200) 0.81 (0.55–1.21)
Small cell 18 (12, 40) 2.19 (1.59–3.02)
Age
560 22 (12, 47) 1
60–69 35 (16, 72) 0.71 (0.55–0.91)
70–79 33 (13, 115) 0.62 (0.48–0.80)
80 or over 97 (19, 4200) 0.41 (0.28–0.58)
Health board
A 30 (14, 76) 1




1 50 (20, 88) 1
2 36 (13, 77) 1.27 (0.96–1.69)
3 35 (18, 67) 1.30 (0.99–1.70)
4 38 (16, 86) 1.13 (0.87–1.48)
5 37 (11, 76) 1.24 (0.93–1.67)
P value (global) 0.445 0.333
P value (trend) 0.264 0.363
Distance to centre
45 km 43 (20, 84) 1
6–37 km 43 (19, 89) 1.03 (0.81–1.31)
38–57 km 27 (14, 66) 1.33 (1.05–1.67)
558 km 44 (14, 77) 1.30 (1.03–1.64)
P value (global) 0.230 0.027
P value (trend) 0.220 0.006
Other variables adjusted for:
Dukes stage
A 55 (27, 118) 1
B 35 (16, 76) 1.33 (0.99–1.78)
C 33 (12, 72) 1.48 (1.07–2.01)
D 31 (14, 79) 1.03 (0.74–1.45)
Not known 66 (44, 4200) 0.32 (0.18–0.57)
Emergency admission
No 54 (27, 95) 1
Yes 15 (3, 36) 2.05 (1.70–2.48)
aCalculated using the Kaplan-Meier method and analysed with the log rank test.
bCalculated using Cox regression (a higher hazard ration indicates quicker treatment).
Lung cancer
    Deprivation quintile
b
    Distance (km) to
    cancer centre
Colorectal cancer























    Distance (km) to
    cancer centre
Figure 2 Adjusted proportional hazard rations for time between ﬁrst
referral and ﬁrst treatment (surgery, chemotherapy or radiotherapy).
aA higher proportional hazard ration indicates faster treatment.
bLeast
deprived is ‘1’ and most deprived ‘5'.
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Others have reported high rates of co-morbidity among deprived
patients and suggested that this may explain their survival disad-
vantage (MacLeod et al, 2000). It could also explain a tendency
for less use of chemotherapy.
With regard to patients in rural areas, we have previously
reported that they have more advanced disease at diagnosis
(Campbell et al, 2001). In a qualitative study, they expressed
concern that their route from referral to diagnosis and treatment
was more complicated (involving peripheral hospitals and outreach
clinics) and therefore slower (Bain and Campbell, 2000). In this
study, however, we found no evidence of increased delays between
referral and treatment–in fact, treatment appeared to be quicker
for patients from outlying areas after adjusting for disease stage
and emergency admissions. The only difference in treatment we
detected was less radiotherapy for colorectal cancer. This ﬁnding
is in line with research in the United States which suggested that
travelling distance was taken into account when considering treat-
ment options of uncertain beneﬁt (Greenberg et al, 1988).
Radiotherapy was not a standard treatment in Scotland for the
majority of patients with colorectal cancer at the time patients in
this study were diagnosed (1995–1996) (SIGN, 1997). On the
other hand, where radiotherapy was a standard treatment (in lung
cancer (SIGN, 1998)), there were no differences in treatment rates.
We have previously reported that more advanced disease at diag-
nosis in rural patients is probably the main reason for their
poorer survival (Campbell et al, 2001). Our current ﬁndings
suggest that they are not substantially disadvantaged after diagnosis
in terms of the treatment they receive, and that any delays in diag-
nosis occur before the point of referral.
In conclusion, deprivation and rural factors may have some
impact on treatment of colorectal and lung cancer. It seems unli-
kely, however, that they are the most important factors
contributing to inequalities in survival, at least in Scotland. For
patients in outlying areas, more advanced stage at diagnosis
remains the most important factor. For the socio-economically
deprived, the reasons for poor survival remain unclear, but are
likely to involve more complex factors than stage at diagnosis
and treatment.
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